Immunocore falls 24% after early Phase 1 data for solid tumor candidate [Seeking Alpha]
Immunocore Holdings plc - American Depositary Shares (IMCR)
Company Research
Source: Seeking Alpha
Immunocore falls 24% after early Phase 1 data for solid tumor candidateSep. 09, 2022 10:30 AM ETImmunocore Holdings plc (IMCR)By:Dulan LokuwithanaSA News EditorluismmolinaU.K.-based biotech Immunocore Holdings plc (NASDAQ:A bi-specific protein basedon the IMCRâ??s therapeutic platform ImmTAC, IMC-F106C, is the companyâ??s first drug candidate to target the PRAME antigen in tumors.The data from the trial will be part of a presentation at the European Society for Medical Oncology (ESMO) Congress today.As of Jul. 18, 55 patients in 10 dose cohorts had received IMC-F106C, and the company said that the drug was well tolerated with well-manageable treatment-related adverse events, which were in line with the mechanism of action.However, the initial three doses were linked to cytokine release syndrome (CRS), mainly classified as Grade 1. None of the TRAEs led to trial discontinuations and death.Meanwhile, in terms of efficacy, 2/6 patients with cutaneous melanoma, 2/4 with ovarian cancer, an
Show less
Read more
Impact Snapshot
Event Time:
IMCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMCR alerts
High impacting Immunocore Holdings plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMCR
News
- Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $81.00 price target on the stock.MarketBeat
- Immunocore to present at upcoming investor conferencesGlobeNewswire
- Immunocore Holdings plc (NASDAQ: IMCR) had its price target raised by analysts at JPMorgan Chase & Co. from $60.00 to $70.00. They now have an "overweight" rating on the stock.MarketBeat
- Immunocore Holdings plc (NASDAQ: IMCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.MarketBeat
- Immunocore presented two posters at CROI 2024 [Yahoo! Finance]Yahoo! Finance
IMCR
Earnings
- 2/28/24 - Miss
IMCR
Sec Filings
- 4/12/24 - Form ARS
- 4/12/24 - Form DEF
- 4/5/24 - Form 8-K
- IMCR's page on the SEC website